RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis

Abstract

Background Long noncoding RNAs (lncRNAs) play crucial roles in tumor progression and are aberrantly expressed in various cancers. However, the functional roles of lncRNAs in breast cancer remain largely unknown. Methods Based on public databases and integrating bioinformatics analyses, the overexpression of lncRNA BCRT1 in breast cancer tissues was detected and further validated in a cohort of breast cancer tissues. The effects of lncRNA BCRT1 on proliferation, migration, invasion and macrophage polarization were determined by in vitro and in vivo experiments. Luciferase reporter assay and RNA immunoprecipitation (RIP) were carried out to reveal the interaction between lncRNA BCRT1, miR-1303, and PTBP3. Chromatin immunoprecipitation (ChIP) and RT-PCR were used to evaluate the regulatory effect of hypoxia-inducible factor-1α (HIF-1α) on lncRNA BCRT1. Results LncRNA BCRT1 was significantly upregulated in breast cancer tissues, which was correlated with poor prognosis in breast cancer patients. LncRNA BCRT1 knockdown remarkably suppressed tumor growth and metastasis in vitro and in vivo. Mechanistically, lncRNA BCRT1 could competitively bind with miR-1303 to prevent the degradation of its target gene PTBP3, which acts as a tumor-promoter in breast cancer. LncRNA BCRT1 overexpression could promote M2 polarization of macrophages, mediated by exosomes, which further accelerated breast cancer progression. Furthermore, lncRNA BCRT1 was upregulated in response to hypoxia, which was attributed to the binding of HIF-1α to HREs in the lncRNA BCRT1 promoter. Conclusions Collectively, these results reveal a novel HIF-1α/lncRNA BCRT1/miR-1303/PTBP3 pathway for breast cancer progression and suggest that lncRNA BCRT1 might be a potential biomarker and therapeutic target for breast cancer.

H19 contributes to aerobic glycolysis, proliferation and immune escape of gastric cancer cells via the miR-519d-3p/LDHA axis

“…It is well known that the lncRNAs' biological function is largely dependent on their subcellular localization [42]. Hence, to explore how H19 regulated LDHA expression in GC cells, we performed cytoplasmic and nuclear separation experiments with RT-qPCR analysis to determine the subcellular localization of H19 and LDHA.…”

Distinct Cargos of Small Extracellular Vesicles Derived from Hypoxic Cells and Their Effect on Cancer Cells

“…Furthermore, miR-21-3p, miR-125b-5p, miR-181d-5p and miR-940 are loaded in sEVs derived from hypoxic ovarian cancer cells and also induce the polarization of macrophages towards a tumor-like M2 phenotype [ 67 , 69 ] by targeting the SOCS4/5/STAT3 signaling pathway [ 69 ]. The lncRNA BRCT1, enriched in breast cancer sEVs was also shown to promote an M2 phenotype in macrophages [ 75 ] and finally, sEVs derived from hypoxic mesenchymal stem cells transfer miR-21-5p, which inhibits PTEN expression levels, subsequently promoting the differentiation of macrophages towards an M2 phenotype [ 85 ].…”

Long noncoding RNA: a dazzling dancer in tumor immune microenvironment

“…In colorectal cancer, tumor-derived exosomes transport lncRNA-RPPH1 into macrophages to induce macrophage M2 polarization, thereby in turn propelling proliferation and metastasis of neoplastic cells [ 47 ]. In breast cancer, tumor cell-derived exosomes can accelerate M2 polarization and strengthen its cancer-promoting function through transmitting lncRNA-BCRT1 [ 48 ]. In HCC, tumor-derived exosomal lncRNA-TUC339 decreases pro-inflammatory cytokine production, alleviates co-stimulatory molecule expression, and compromises phagocytosis in environmental macrophages [ 49 ].…”